BIO-TECHNE CORP holding history
As of Nov. 6, 2026 (UTC)
| March 31, 2025 | 2,448,322 | $143,545,119 | 1.04% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 14, 2025 |
| June 30, 2025 | 2,665,684 | $137,149,442 | 0.96% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 12, 2025 |
| Sept. 30, 2025 | 1,702,243 | $94,695,778 | 0.71% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Nov. 12, 2025 |
| Dec. 31, 2025 | 1,403,769 | $82,555,655 | 0.84% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Feb. 13, 2026 |
| March 31, 2026 | 1,454,171 | $75,994,976 | 0.96% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 13, 2026 |
| June 30, 2026 | 434,731 | $30,713,745 | 0.79% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 12, 2026 |
6 rows · Sort by column; scroll horizontally for more.
No rows match these filters.
Schedule 13G disclosures
No verified related disclosures are included in this freeze.
About reported holdings
13F reports quarter-end securities, excluding cash and shorts. Position changes do not establish trades, motives or returns; portfolio weights use disclosed 13F value.